Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis

Anti-membrane autoantibodies (MbA) have been reported in sera from patients with lupus nephritis (LN) but the targets of the MbA remain to be explored, which is the aim of the current study. Sera were collected from 40 patients with LN determined by renal biopsy, and from 30 systemic lupus erythemat...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2015
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/24939
Acceso en línea:
https://doi.org/10.1016/j.jaut.2015.05.009
https://repository.urosario.edu.co/handle/10336/24939
Palabra clave:
Actinin
Adolescent
Adult
Aged
Autoantibodies
Cell Membrane
Cells
Cultured
Enzyme-Linked Immunosorbent Assay
Female
Flow Cytometry
HEK293 Cells
Humans
Immunoglobulin G
Lupus Erythematosus
Systemic
Lupus Nephritis
Male
Mesangial Cells
Middle Aged
Young Adult
Rights
License
Bloqueado (Texto referencial)
id EDOCUR2_3f32219f145dae7bd72499850e797a85
oai_identifier_str oai:repository.urosario.edu.co:10336/24939
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling d85d963f-ad7d-401f-be05-8c4d0a2a0dec5f5c23f0-ee43-4877-937e-0c8fd083c99e9f23b61e-3145-4be6-8fbe-9e61b10098d3d32b074e-5826-428f-b793-28a9e285e2c42679b5b9-6674-475f-99e7-71e606d146608b90d0a7-8ec8-4283-996b-35099941f0aeb5c01494-7bdd-475e-a90a-3e844f9c864a8453131a-afbc-460b-84e0-39eb3a26b660e80d49fb-662e-46ce-83e2-7e4de758b779e824dfae-ba3d-4702-8fbe-36f935241ad052249701194747786000dd68302-e798-41a5-a9c4-4991e54eb2022020-06-11T13:21:52Z2020-06-11T13:21:52Z2015-07Anti-membrane autoantibodies (MbA) have been reported in sera from patients with lupus nephritis (LN) but the targets of the MbA remain to be explored, which is the aim of the current study. Sera were collected from 40 patients with LN determined by renal biopsy, and from 30 systemic lupus erythematosus (SLE) patients without clinical evidence of LN. Thirty autoimmune disease control patients (rheumatoid arthritis, Sjogren's syndrome and systemic sclerosis), and 30 healthy controls were also included. Using flow cytometry, the presence of anti-MbA was explored revealing that IgG anti-MbA positivity was associated with LN (62.5% vs 13.3%) when compared to non-LN SLE patients, autoimmune disease patients (6.7%) and healthy controls (0%). Next, using purified plasma membrane fractions from human embryonic kidney (HEK) cells, the more prominent targets and their occurrence rates were located at 50 kDa, 60/65 kDa, 90 kDa, 110 kDa, 180 kDa and 220 kDa. Alpha-actinin (110 kDa) autoAb was characterized as a major target in LN patients positive for anti-MbA, and anti-MbA binding activity was reduced (36.9 +/- 13.7%) in the presence of alpha-actinin. Laminin (200 kDa) was also characterized as a minor target, which was not the case for annexin A2 (36 kDa). Finally, anti-MbA IgG subclass analysis indicated a predominance of IgG2. In conclusion, IgG anti-MbA were detected at high levels in LN patients supporting a primary pathogenic role for anti-MbA and anti-MbA/alpha-actinin+ in LN that needs further research. (C) 2015 Elsevier Ltd. All rights reserved.application/pdfhttps://doi.org/10.1016/j.jaut.2015.05.0090896-84111095-9157https://repository.urosario.edu.co/handle/10336/24939engJournal of Autoimmunity6154Journal of AutoimmunityVol. 61Journal of Autoimmunity, ISSN: 0896-8411;1095-9157, Vol.61, No. (2015-07); pp. 54-61https://app.dimensions.ai/details/publication/pub.1004921433Bloqueado (Texto referencial)http://purl.org/coar/access_right/c_14cbinstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURActininAdolescentAdultAgedAutoantibodiesCell MembraneCellsCulturedEnzyme-Linked Immunosorbent AssayFemaleFlow CytometryHEK293 CellsHumansImmunoglobulin GLupus ErythematosusSystemicLupus NephritisMaleMesangial CellsMiddle AgedYoung AdultAnti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritisarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Seret, GuillaumeCañas, FelipeCostanzo, Laurence Pougnet-DiHanrotel-Saliou, CatherineJousse-Joulin, SandrineLe Meur, YannickSaraux, AlainValeri, AntoinePutterman, ChaimYouinou, PierreRojas-Villarraga, AdrianaAnaya, Juan-ManuelRenaudineau, Yves10336/24939oai:repository.urosario.edu.co:10336/249392021-08-11 17:28:02.394https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis
title Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis
spellingShingle Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis
Actinin
Adolescent
Adult
Aged
Autoantibodies
Cell Membrane
Cells
Cultured
Enzyme-Linked Immunosorbent Assay
Female
Flow Cytometry
HEK293 Cells
Humans
Immunoglobulin G
Lupus Erythematosus
Systemic
Lupus Nephritis
Male
Mesangial Cells
Middle Aged
Young Adult
title_short Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis
title_full Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis
title_fullStr Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis
title_full_unstemmed Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis
title_sort Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis
dc.subject.keyword.spa.fl_str_mv Actinin
Adolescent
Adult
Aged
Autoantibodies
Cell Membrane
Cells
Cultured
Enzyme-Linked Immunosorbent Assay
Female
Flow Cytometry
HEK293 Cells
Humans
Immunoglobulin G
Lupus Erythematosus
Systemic
Lupus Nephritis
Male
Mesangial Cells
Middle Aged
Young Adult
topic Actinin
Adolescent
Adult
Aged
Autoantibodies
Cell Membrane
Cells
Cultured
Enzyme-Linked Immunosorbent Assay
Female
Flow Cytometry
HEK293 Cells
Humans
Immunoglobulin G
Lupus Erythematosus
Systemic
Lupus Nephritis
Male
Mesangial Cells
Middle Aged
Young Adult
description Anti-membrane autoantibodies (MbA) have been reported in sera from patients with lupus nephritis (LN) but the targets of the MbA remain to be explored, which is the aim of the current study. Sera were collected from 40 patients with LN determined by renal biopsy, and from 30 systemic lupus erythematosus (SLE) patients without clinical evidence of LN. Thirty autoimmune disease control patients (rheumatoid arthritis, Sjogren's syndrome and systemic sclerosis), and 30 healthy controls were also included. Using flow cytometry, the presence of anti-MbA was explored revealing that IgG anti-MbA positivity was associated with LN (62.5% vs 13.3%) when compared to non-LN SLE patients, autoimmune disease patients (6.7%) and healthy controls (0%). Next, using purified plasma membrane fractions from human embryonic kidney (HEK) cells, the more prominent targets and their occurrence rates were located at 50 kDa, 60/65 kDa, 90 kDa, 110 kDa, 180 kDa and 220 kDa. Alpha-actinin (110 kDa) autoAb was characterized as a major target in LN patients positive for anti-MbA, and anti-MbA binding activity was reduced (36.9 +/- 13.7%) in the presence of alpha-actinin. Laminin (200 kDa) was also characterized as a minor target, which was not the case for annexin A2 (36 kDa). Finally, anti-MbA IgG subclass analysis indicated a predominance of IgG2. In conclusion, IgG anti-MbA were detected at high levels in LN patients supporting a primary pathogenic role for anti-MbA and anti-MbA/alpha-actinin+ in LN that needs further research. (C) 2015 Elsevier Ltd. All rights reserved.
publishDate 2015
dc.date.created.spa.fl_str_mv 2015-07
dc.date.accessioned.none.fl_str_mv 2020-06-11T13:21:52Z
dc.date.available.none.fl_str_mv 2020-06-11T13:21:52Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1016/j.jaut.2015.05.009
dc.identifier.issn.none.fl_str_mv 0896-8411
1095-9157
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/24939
url https://doi.org/10.1016/j.jaut.2015.05.009
https://repository.urosario.edu.co/handle/10336/24939
identifier_str_mv 0896-8411
1095-9157
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 61
dc.relation.citationStartPage.none.fl_str_mv 54
dc.relation.citationTitle.none.fl_str_mv Journal of Autoimmunity
dc.relation.citationVolume.none.fl_str_mv Vol. 61
dc.relation.ispartof.spa.fl_str_mv Journal of Autoimmunity, ISSN: 0896-8411;1095-9157, Vol.61, No. (2015-07); pp. 54-61
dc.relation.uri.spa.fl_str_mv https://app.dimensions.ai/details/publication/pub.1004921433
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_14cb
dc.rights.acceso.spa.fl_str_mv Bloqueado (Texto referencial)
rights_invalid_str_mv Bloqueado (Texto referencial)
http://purl.org/coar/access_right/c_14cb
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Journal of Autoimmunity
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167537372364800